114 related articles for article (PubMed ID: 11504833)
1. Glucose transporter Glut-1 is of limited value for detecting breast carcinoma in serous effusions.
Zimmerman RL; Goonewardene S; Fogt F
Mod Pathol; 2001 Aug; 14(8):748-51. PubMed ID: 11504833
[TBL] [Abstract][Full Text] [Related]
2. GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions.
Burstein DE; Reder I; Weiser K; Tong T; Pritsker A; Haber RS
Mod Pathol; 1998 Apr; 11(4):392-6. PubMed ID: 9578091
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids.
Shen J; Pinkus GS; Deshpande V; Cibas ES
Am J Clin Pathol; 2009 Apr; 131(4):516-23. PubMed ID: 19289587
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of GLUT-1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine-needle aspiration biopsy material.
Weiner MF; Miranda RN; Bardales RH; Mukunyadzi P; Baker SJ; Korourian S; De Las Casas LE
Diagn Cytopathol; 2004 Nov; 31(5):294-9. PubMed ID: 15468132
[TBL] [Abstract][Full Text] [Related]
5. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
Zhu W; Michael CW
Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
Afify A; Zhou H; Howell L; Paulino AF
Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
[TBL] [Abstract][Full Text] [Related]
7. Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions.
Lagana SM; Taub RN; Borczuk AC
Arch Pathol Lab Med; 2012 Jul; 136(7):804-9. PubMed ID: 22742553
[TBL] [Abstract][Full Text] [Related]
8. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
Ciampa A; Fanger G; Khan A; Rock KL; Xu B
Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
[TBL] [Abstract][Full Text] [Related]
9. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
10. The utility of GLUT-1 immunolocalization in cell blocks: An adjunct to the fine needle aspiration diagnosis of cystic squamous lesions of the head and neck.
Chandan VS; Faquin WC; Wilbur DC; Khurana KK
Cancer; 2006 Apr; 108(2):124-8. PubMed ID: 16435376
[TBL] [Abstract][Full Text] [Related]
11. Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumors of the ovary.
Cantuaria G; Magalhaes A; Penalver M; Angioli R; Braunschweiger P; Gomez-Marin O; Kanhoush R; Gomez-Fernandez C; Nadji M
Gynecol Oncol; 2000 Oct; 79(1):33-7. PubMed ID: 11006027
[TBL] [Abstract][Full Text] [Related]
12. The value of the immunoperoxidase slide assay in the diagnosis of malignant pleural effusions in breast cancer.
Guzman J; Costabel U; Bross KJ; Wiehle U; Grunert F; Schaefer HE
Acta Cytol; 1988; 32(2):188-92. PubMed ID: 3279712
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.
Monaco SE; Shuai Y; Bansal M; Krasinskas AM; Dacic S
Am J Clin Pathol; 2011 Apr; 135(4):619-27. PubMed ID: 21411785
[TBL] [Abstract][Full Text] [Related]
14. nm23 is expressed in reactive mesothelium and is not useful for detection of malignant cells in serous effusions.
Zimmerman RL; Fogt F
Oncol Rep; 2006 Jan; 15(1):85-8. PubMed ID: 16328038
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of a second generation CA 15-3 antibody to detect adenocarcinoma in body cavity effusions.
Zimmerman RL; Fogt F; Goonewardene S
Cancer; 2000 Aug; 90(4):230-4. PubMed ID: 10966563
[TBL] [Abstract][Full Text] [Related]
16. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations.
Ikeda K; Tate G; Suzuki T; Kitamura T; Mitsuya T
Diagn Cytopathol; 2011 Jun; 39(6):395-401. PubMed ID: 21574259
[TBL] [Abstract][Full Text] [Related]
18. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
Davidson B; Baekelandt M; Shih IeM
Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
[TBL] [Abstract][Full Text] [Related]
19. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(5):2635-9. PubMed ID: 12529975
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
Afify AM; Stern R; Michael CW
Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
